Citations

Clear

4847 citation(s) found for "Yu, Eric".

Endovascular Treatment of Basilar Bifurcation Aneurysms With PulseRider-Assisted Coiling: 2-Dimensional Operative Video
Sattur, Mithun G. , Kasab, Sami Al , Spiotta, Alejandro M , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond, Veznedaroglu, Erol, Welch, Babu G. , White, Jonathan, Spiotta, Alejandro M , Schirmer, Clemens M , Porto, Guilherme , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Tawk, Rabih G. , Thomas, Ajith J , White, Jonathan A.

Mayo Clinic

Operative Neurosurgery | April 17, 2021 | Volume: 21 | Issue: 2 | Pages: E109-E110

10.1093/ons/opab102 | PMID 33861344 Get It

Abstract Wide-necked bifurcation aneurysms pose technical and anatomical challenges to endovascular treatment, which make the simpler assisted (balloon or single stent) coiling techniques less effective. 1 Consequently, unique endovascular solutions to treat such aneurysms have been devised. 2,3 One such device is PulseRider (Cerenovus, New Brunswick, New Jersey), which is designed to provide neck support for a coil mass while protecting the bifurcation. 3 The device comprises a body or stem that is deployed in the parent artery and a saddle component that sits at the aneurysm neck to keep the coil mass away from the bifurcation. There are several technical nuances involved in successful use of the device during positioning, deployment, and detachment. 3 We present a surgical video detailing the steps of PulseRider-assisted coiling of unruptured basilar bifurcation (or basilar apex) aneurysms. The first case highlights index treatment at diagnosis and the second showcases treatment of a recurrent basilar apex aneurysm. Both patients provided informed consent to the procedure. We also briefly discuss the rationale for treating basilar apex aneurysms. 4,5
Middle Cerebral Artery Thrombectomy: Clinical Findings and Technical Pearls: 2-Dimensional Operative Video
Rangwala, Shivani D. , Selvan, Pradeep, Tenser, Matthew, Mack, William J. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , Schirmer, Clemens M , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Tawk, Rabih G. , Thomas, Ajith J , White, Jonathan Samuel

Mayo Clinic

Operative Neurosurgery | April 17, 2021 | Volume: 21 | Issue: 2 | Pages: E107-E108

10.1093/ons/opab101 | PMID 33861327 Get It

Abstract Mechanical thrombectomy as a treatment for large vessel occlusion to achieve rapid revascularization is supported in the literature. 1-3 The presenting symptoms will localize to functions of the ischemic area. The middle cerebral artery (MCA) supplies areas of the frontal, temporal, and parietal cortices, as well as the basal ganglia. Occlusion of the MCA will present with contralateral hemiplegia, sensory loss, and, if the dominant hemisphere is involved, language deficits. We present a right-hand-dominant 79-yr-old female with right MCA syndrome—her last known well time was 1.5 h prior to presentation. Her NIH (National Institutes of Health) Stroke Scale was 16, most notable for left hemiplegia. Although the patient presented early in the clinical time course, as part of our institution protocol, a computed tomography (CT) head, CT perfusion, and CT angiogram (CTA) were performed. CT head did not demonstrate acute hemorrhage, so she received intravenous tissue plasminogen activator. CTA demonstrated a right MCA occlusion and CT perfusion suggested a large area of salvageable tissue, so she was taken to the angiography suite for mechanical thrombectomy. Angiography of the right internal carotid artery (ICA) showed MCA occlusion (insular segment). A thrombectomy device was deployed over the area of occlusion and allowed to engage for 5 min. An aspiration catheter was advanced over the stentriever up against the clot. The stentriever device was withdrawn under continuous aspiration and follow-up angiography showed complete reperfusion. The patient demonstrated improvement and was eventually discharged to an inpatient rehabilitation center. Patient provided consent for photography per university protocol. Institutional review board (IRB) approval was not needed for the single-patient data included in this report.
Recognizing and Preventing Participant Deception in Online Nicotine and Tobacco Research Studies: Suggested Tactics and a Call to Action
Heffner, Jaimee L. , Watson, Noreen L , Dahne, Jennifer , Croghan, Ivana T. , Kelly, Megan M. , McClure, Jennifer B. , Bars, Matthew P, Thrul, Johannes , Meier, Eric , Meier, Eric N. , Croghan, Ivana, Meier, Eric

Mayo Clinic

Nicotine & Tobacco Research | April 16, 2021 | Volume: 23 | Issue: 10 | Pages: 1810-1812

10.1093/ntr/ntab077 | PMID 33876244 Get It

Patient-reported outcome improvements at 24-month follow-up after fusion added to decompression for grade I degenerative lumbar spondylolisthesis: a multicenter study using the Quality Outcomes Database
Bisson, Erica F. , Bydon, Mohamad , Alvi, Mohammed Ali , Glassman, Steven D. , Foley, Kevin T. , Potts, Eric A. , Shaffrey, Christopher I. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Yew, Andrew, Haid, Regis W., Chan, Andrew K. , Mummaneni, Praveen V. , Alvi, Mohammed A, Alvi, Mohammed Ali , Guan, Jian , Goyal, Anshit

Mayo Clinic

Journal of Neurosurgery: Spine | April 16, 2021 | Volume: 35 | Issue: 1 | Pages: 42-51

10.3171/2020.9.spine201082 | PMID 33862593 Get It

OBJECTIVE The ideal surgical management of grade I lumbar spondylolisthesis has not been determined despite extensive prior investigations. In this cohort study, the authors used data from the large, multicenter, prospectively collected Quality Outcomes Database to bridge the gap between the findings in previous randomized trials and those in a more heterogeneous population treated in a typical practice. The objective was to assess the difference in patient-reported outcomes among patients undergoing decompression alone or decompression plus fusion. METHODS The primary outcome measure was change in 24-month Oswestry Disability Index (ODI) scores. The minimal clinically important difference (MCID) in ODI score change and 30% change in ODI score at 24 months were also evaluated. After adjusting for patient-specific and clinical factors, multivariable linear and logistic regressions were employed to evaluate the impact of fusion on outcomes. To account for differences in age, sex, body mass index, and baseline listhesis, a sensitivity analysis was performed using propensity score analysis to match patients undergoing decompression only with those undergoing decompression and fusion. RESULTS In total, 608 patients who had grade I lumbar spondylolisthesis were identified (85.5% with at least 24 months of follow-up); 140 (23.0%) underwent decompression alone and 468 (77.0%) underwent decompression and fusion. The 24-month change in ODI score was significantly greater in the fusion plus decompression group than in the decompression-only group (−25.8 ± 20.0 vs −15.2 ± 19.8, p < 0.001). Fusion remained independently associated with 24-month ODI score change (B = −7.05, 95% CI −10.70 to −3.39, p ≤ 0.001) in multivariable regression analysis, as well as with achieving the MCID for the ODI score (OR 1.767, 95% CI 1.058–2.944, p = 0.029) and 30% change in ODI score (OR 2.371, 95% CI 1.286–4.371, p = 0.005). Propensity score analysis resulted in 94 patients in the decompression-only group matched 1 to 1 with 94 patients in the fusion group. The addition of fusion to decompression remained a significant predictor of 24-month change in the ODI score (B = 2.796, 95% CI 2.228–13.275, p = 0.006) and of achieving the 24-month MCID ODI score (OR 2.898, 95% CI 1.214–6.914, p = 0.016) and 24-month 30% change in ODI score (OR 2.300, 95% CI 1.014–5.216, p = 0.046). CONCLUSIONS These results suggest that decompression plus fusion in patients with grade I lumbar spondylolisthesis may be associated with superior outcomes at 24 months compared with decompression alone, both in reduction of disability and in achieving clinically meaningful improvement. Longer-term follow-up is warranted to assess whether this effect is sustained.
Comparison of Chest CT Findings of COVID-19, Influenza, and Organizing Pneumonia: A Multireader Study
Garrana, Sherief , Som, Avik , Ndakwah, Gabrielle S., Yeung, Tristan, Febbo, Jennifer , Heeger, Allen , Lang, Min , McDermott, Shaunagh , Mendoza, Dexter P. , Zhang, Éric , Sharma, Amita , Little, Brent P. , Sharma, Amita , Yeung, Tristan, Narayan, Anand K.

Mayo Clinic

American Journal of Roentgenology | April 14, 2021 | Volume: 217 | Issue: 5 | Pages: 1093-1102

10.2214/ajr.21.25640 | PMID 33852360 Get It

High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
Michieli, Laura De , Ola, Olatunde , Knott, Jonathan D , Akula, Ashok , Mehta, Ramila A. , Hodge, David O. , Dworak, Marshall , Gharacholou, Michael, Singh, Gurpreet , Singh, Ripudamanjit, Gulati, Rajiv , Jaffe, Allan S. , Sandoval, Yader , De Michieli, Laura, De Michieli, Laura , Yang, Eric H. , Singh, Gurpreet, Jaffe, Allan S.

Mayo Clinic

Clinical Chemistry | April 12, 2021 | Volume: 67 | Issue: 8 | Pages: 1080-1089

10.1093/clinchem/hvab062 | PMID 33860295 Get It

Abstract Background Limited data exist on high-sensitivity cardiac troponin (hs-cTn) for risk-stratification in COVID-19. Methods We conducted a multicenter, retrospective, observational, US-based study of COVID-19 patients undergoing hs-cTnT. Outcomes included short-term mortality (in-hospital and 30-days post-discharge) and a composite of major adverse events, including respiratory failure requiring mechanical ventilation, cardiac arrest, and shock within the index presentation and/or mortality during the index hospitalization or within 30-days post-discharge. Results Among 367 COVID-19 patients undergoing hs-cTnT, myocardial injury was identified in 46%. They had a higher risk for mortality (20% vs 12%, P &lt; 0.0001; unadjusted HR 4.44, 95% CI 2.13–9.25, P &lt; 0.001) and major adverse events (35% vs. 11%, P &lt; 0.0001; unadjusted OR 4.29, 95% CI 2.50–7.40, P &lt; 0.0001). Myocardial injury was associated with major adverse events (adjusted OR 3.84, 95% CI 2.00–7.36, P &lt; 0.0001) but not mortality. Baseline (adjusted OR 1.003, 95% CI 1.00–1.007, P = 0.047) and maximum (adjusted OR 1.005, 95% CI 1.001–1.009, P = 0.0012) hs-cTnT were independent predictors of major adverse events. Most (95%) increases were due to myocardial injury, with 5% (n = 8) classified as type 1 or 2 myocardial infarction. A single hs-cTnT &lt;6 ng/L identified 26% of patients without mortality, with a 94.9% (95% CI 87.5–98.6) negative predictive value and 93.1% sensitivity (95% CI 83.3–98.1) for major adverse events in those presenting to the ED. Conclusions Myocardial injury is frequent and prognostic in COVID-19. While most hs-cTnT increases are modest and due to myocardial injury, they have important prognostic implications. A single hs-cTnT &lt;6 ng/L at presentation may facilitate the identification of patients with a favorable prognosis.
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
Lee, Seohyuk , Zhang, Sui , Ou, Fang‐Shu , Wolfe, Eric, Ogino, Shuji , Niedzwiecki, Donna , Mowat, Rex B., Whittom, Renaud , Hantel, Alexander, Benson, Al B. , Atienza, Daniel, Messino, Michael J., Kindler, Hedy L. , Gross, Cary P. , Irwin, Melinda L. , Meyerhardt, Jeffrey A. , Fuchs, Charles S. , Ou, Fang-Shu , Wolfe, Eric G, Ogino, Shuji , Kindler, Hedy , Venook, Alan P , Fuchs, Charles S , Meyerhardt, Jeffrey A , Niedzwiecki, Donna , Ma, Chao , Saltz, Leonard B. , Mayer, Robert J. , Venook, Alan P.

Mayo Clinic

JNCI Cancer Spectrum | April 11, 2021 | Volume: 5 | Issue: 3 | Pages: No page available

10.1093/jncics/pkab034 | PMID 34104867 Get It

Abstract Background Disparities in colon cancer outcomes have been reported across race and socioeconomic status, which may reflect, in part, access to care. We sought to assess the influences of race and median household income (MHI) on outcomes among colon cancer patients with similar access to care. Methods We conducted a prospective, observational study of 1206 stage III colon cancer patients enrolled in the CALGB 89803 randomized adjuvant chemotherapy trial. Race was self-reported by 1116 White and 90 Black patients at study enrollment; MHI was determined by matching 973 patients’ home zip codes with publicly available US Census 2000 data. Multivariate analyses were adjusted for baseline sociodemographic, clinical, dietary, and lifestyle factors. All statistical tests were 2-sided. Results Over a median follow-up of 7.7 years, the adjusted hazard ratios for Blacks (compared with Whites) were 0.94 (95% confidence interval [CI] = 0.66 to 1.35, P = .75) for disease-free survival, 0.91 (95% CI = 0.62 to 1.35, P = .65) for recurrence-free survival, and 1.07 (95% CI = 0.73 to 1.57, P = .73) for overall survival. Relative to patients in the highest MHI quartile, the adjusted hazard ratios for patients in the lowest quartile were 0.90 (95% CI = 0.67 to 1.19, Ptrend = .18) for disease-free survival, 0.89 (95% CI = 0.66 to 1.22, Ptrend = .14) for recurrence-free survival, and 0.87 (95% CI = 0.63 to 1.19, Ptrend = .23) for overall survival. Conclusions In this study of patients with similar health-care access, no statistically significant differences in outcomes were found by race or MHI. The substantial gaps in outcomes previously observed by race and MHI may not be rooted in differences in tumor biology but rather in access to quality care.
Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia
Kharfan‐Dabaja, Mohamed A. , Brissot, Éolia , Kroger, Nicolaus , Ciceri, Fabio , Deconinck, Éric , Blaise, Didier , Chevallier, Patrice , Gramatzki, Martin , Ganser, Arnold , Stelljes, Matthias , Sanz, Jaime , Nagler, Arnon , Mohty, Mohamad , Kröger, Nicolaus , Mohty, Mohamad , Kroger, Nicolaus , Ciceri, Fabio , Deconinck, Eric , Gramatzki, Martin , Ruggeri, Annalisa , Mohty, Mohamad , Blaise, Didier , Kröger, Nicolaus , Mohty, Mohamad , Labopin, Myriam , Finke, Jürgen , Edinger, Matthias , Savani, Bipin N.

Mayo Clinic

British Journal of Haematology | April 10, 2021 | Volume: 193 | Issue: 3 | Pages: 592-601

10.1111/bjh.17426 | PMID 33838047 Get It

SummaryOptimal donor choice for a second allogeneic haematopoietic cell transplant (allo‐HCT) in relapsed acute myeloid leukaemia (AML) remains unknown. We compared overall survival (OS) using registry data from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) involving 455 adults who received a second allo‐HCT from a human leucocyte antigen (HLA)‐matched unrelated (MUD) (n = 320) or a haploidentical (n = 135) donor. Eligibility criteria required adults aged ≥18 years who received a second allo‐HCT for treating AML relapse between 2005 and 2019. The primary end‐point was OS. There was no statistically significant difference in the median (interquartile range) age between the groups, MUD 46 (35–58) versus haploidentical 44 (33–53) years (P = 0·07). The median OS was not different between the MUD and the haploidentical groups (10 vs. 11 months, P = 0·57). Similarly, the 2‐year OS was 31% for the MUD and 29% for the haploidentical donor groups. The OS was worse if the procedure was performed with active AML [hazard ratio (HR) 1·42, 95% confidence interval (CI) 1·07–1·89; P = 0·02]. Conversely, a longer time from first allo‐HCT to relapse (>13·2 months) was associated with better OS (HR 0·50, 95% CI 0·37–0·69; P < 0·0001). The results of the present analysis limit the ability to recommend one donor type over another when considering a second allo‐HCT for relapsed AML. Our findings highlight that best OS is achieved when receiving the second allo‐HCT in complete remission.
Relationships Between Time-at-Bedside During Hospital Ward Rounds, Clinician–Patient Agreement, and Patient Experience
Ratelle, John T. , Herberts, Michelle , Miller, Donna , Kumbamu, Ashok , Lawson, Donna K. , Beckman, Thomas J. , Lawson, Donna, Polley, Eric, Miller, Donna M , Polley, Eric C.

Mayo Clinic

Journal of Patient Experience | April 9, 2021 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/23743735211008303 | PMID 34179432 Get It

Hospital medicine ward rounds are often conducted away from patients’ bedsides, but it is unknown if more time-at-bedside is associated with improved patient outcomes. Our objective is to measure the association between “time-at-bedside,” patient experience, and patient–clinician care agreement during ward rounds. Research assistants directly observed medicine services to quantify the amount of time spent discussing each patient’s care inside versus outside the patient’s room. “Time-at-bedside” was defined as the proportion of time spent discussing a patient’s care in his or her room. Patient experience and patient–clinician care agreement both were measured immediately after ward rounds. Results demonstrated that the majority of patient and physicians completely agreement on planned tests (66.3%), planned procedures (79.7%), medication changes (50.6%), and discharge location (66.9%), but had no agreement on the patient’s main concern (74.4%) and discharge date (50.6%). Time-at-bedside was not correlated with care agreement or patient experience ( P > .05 for all comparisons). This study demonstrates that spending more time at the bedside during ward rounds, alone, is insufficient to improve patient experience.
Per pass analysis of thrombus composition retrieved by mechanical thrombectomy
Abbasi, Mehdi , Kvamme, Peter , Patel, Biraj M. , Gounis, Matthew J. , Kadirvel, Ramanathan , Kallmes, David F. , Doyle, Karen , Cloft, Harry J. , Liu, Yang , Thacker, Ike, Aghaebrahim, Amin, Sauvageau, Eric , Copelan, Alexander , Nazari, Pouya , Cantrell, Donald R. , Bhuva, Parita, Soomro, Jazba , Mohammaden, Mahmoud , Pisani, Leonardo , Puri, Ajit S , Brinjikji, Waleed , Patel, Biraj M , Fitzgerald, Seán , Mereuta, Oana M, Dai, Daying , Kadirvel, Ram , Kallmes, David F , Savastano, Luis E., Kayan, Yasha , Nazari, Pouya , Al-Bayati, Alhamza , Brinjikji, Waleed , Liu, Yang , Layton, Kennith F. , Hanel, Ricardó A. , Almekhlafi, Mohammed , Almandoz, Josser E Delgado , Mendes Pereira, Vitor , Jahromi, Babak S. , Yoo, Albert J. , Nogueira, Raul G. , Fitzgerald, Seán , Mereuta, Oana Madalina , Dai, Daying , Savastano, Luis , Demchuk, Andrew M. , Entwistle, John, Haussen, Diogo C , Al‐Bayati, Alhamza R , Rodrigues, Gabriel Martins

Mayo Clinic

Interventional Neuroradiology | April 7, 2021 | Volume: 27 | Issue: 6 | Pages: 815-820

10.1177/15910199211009119 | PMID 33823621 Get It

Background and aim Mechanical thrombectomy (MT) for large vessel occlusion often requires multiple passes to retrieve the entire thrombus load. In this multi-institutional study we sought to examine the composition of thrombus fragments retrieved with each pass during MT. Methods Patients who required multiple passes during thrombectomy were included. Histopathological evaluation of thrombus fragments retrieved from each pass was performed using Martius Scarlet Blue staining and the composition of each thrombus component including RBC, fibrin and platelet was determined using image analysis software. Results 154 patients underwent MT and 868 passes was performed which resulted in 263 thrombus fragments retrieval. The analysis of thrombus components per pass showed higher RBC, lower fibrin and platelet composition in the pass 1 and 2 when compared to pass 3 and passes 4 or more combined (P values <0.05). There were no significant differences between thrombus fragments retrieved in pass 1 and pass 2 in terms of RBC, WBC, fibrin, and platelet composition (P values >0.05). Similarly, when each composition of thrombus fragments retrieved in pass 3 and passes 4 or more combined were compared with each other, no significant difference was noted (P values >0.05). Conclusion Our findings confirm that thrombus fragments retrieved with each pass differed significantly in histological content. Fragments in the first passes were associated with lower fibrin and platelet composition compared to fragments retrieved in passes three and four or higher. Also, thrombus fragments retrieved after failed pass were associated with higher fibrin and platelet components.